ALTHE — Theraclion SA Share News
0.000.00%
Last trade - 00:00- €41.86m
- €43.43m
- €1.19m
Brief: Theraclion Secures U.S. Reimbursement Milestone for Sonovein With New Category III CPT Code
French and Benelux stocks-Factors to watch
Brief: Inner Mongolia Furui Medical Raises Stake In Theraclion
Brief: French medical technology company Theraclion strikes partnership with Chinese company Furui and names new CEO
Brief: Theraclion FY Net Loss Widens To EUR 5 Million
Brief: Theraclion: FDA Approves Pivotal Varicose Veins Study With Theraclion's Sonovein®
French and Benelux stocks-Factors to watch
Brief: Theraclion/SONOVEIN®: Results Of First US Trial
Brief: Theraclion: David Caumartin Steps Down As CEO
Brief: Theraclion: Last Patient Of First SONOVEIN U.S. Study Has Been Treated
Brief: Theraclion: New Partnership With Victor Dupouy Hospital Centre On Echotherapy For Varicose Veins
French and Benelux stocks-Factors to watch
Brief: Theraclion End-June Operating Loss Widens To EUR 3.4 Mln
Brief: Theraclion Announces First Patients Treated With SONOVEIN
Brief: Theraclion FY Operating Loss Widens To EUR 4.5 Mln
Brief: Theraclion Announces First Patient Inclusion In Early-Stage Breast Cancer Study
Brief: Theraclion FY Turnover Doubles To EUR 1.5 Mln
Brief: Theraclion Appoints Yann Duchesne As New Executive Chairman
Brief: Theraclion Announces Completion Of First Varicose Veins Echotherapy Treatment In China